Poussin, Carine
Titz, Bjoern
Xiang, Yang
Baglia, Laurel
Berg, Rachel
Bornand, David
Choukrallah, Mohammed-Amin
Curran, Timothy
Dijon, Sophie
Dossin, Eric
Dulize, Remi
Etter, Doris
Fatarova, Maria
Medlin, Loyse Felber
Haiduc, Adrian
Kishazi, Edina
Kolli, Aditya R.
Kondylis, Athanasios
Kottelat, Emmanuel
Laszlo, Csaba
Lavrynenko, Oksana
Eb-Levadoux, Yvan
Nury, Catherine
Peric, Dariusz
Rizza, Melissa
Schneider, Thomas
Guedj, Emmanuel
Calvino, Florian
Sierro, Nicolas
Guy, Philippe
Ivanov, Nikolai V.
Picavet, Patrick
Spinelli, Sherry
Hoeng, Julia
Peitsch, Manuel C.
Funding for this research was provided by:
Philip Morris International is the sole source of funding and sponsor of this research.
Article History
Received: 19 June 2023
Accepted: 12 February 2024
First Online: 21 February 2024
Competing interests
: The authors—except SS, TC, LB, and RB—are employees of Philip Morris International or were at the time of the study. JH is now an employee of Vectura Fertin Pharma. Philip Morris International is the sole source of funding and sponsor of this research.